Related Experiment Videos
Medicated versus saline nose drops in the management of upper respiratory infection
Insights
Medicated nose drops are not essential for treating upper respiratory infections in children. A study found no significant difference in recovery between medicated, saline, or no nose drops for infants and toddlers.
Area of Science:
- Pediatrics
- Otolaryngology
- Infectious Diseases
Background:
- Upper respiratory infections (URIs) are common in infants and young children.
- Rhinitis is a frequent symptom of URIs, often managed with various treatments.
- The efficacy of medicated nose drops in pediatric URI management is not well-established.
Purpose of the Study:
- To evaluate the effectiveness of medicated nose drops compared to saline nose drops and no treatment for pediatric URIs.
- To determine if medicated nose drops offer a significant benefit in symptom resolution for young children.
Main Methods:
- A randomized controlled trial involving 74 children aged 3 weeks to 2 years with URI symptoms.
- Participants were assigned to three groups: medicated nose drops, saline nose drops, or no nose drops.
- Improvement was assessed in 46 children who returned for a follow-up 2 days later.
Main Results:
- All participants, regardless of treatment group, showed improvement in symptoms between the initial visit and the 2-day follow-up.
- No statistically significant difference in clinical improvement was observed between the group receiving medicated nose drops, the saline nose drops group, and the control group.
Conclusions:
- Medicated nose drops are not essential for the treatment of upper respiratory infections and rhinitis in young children.
- Current evidence suggests that conservative management, such as saline or no nose drops, may be as effective as medicated options for pediatric URIs.
Abstract:
Seventy-four children from three weeks to two years of age with various upper respiratory symptoms were randomly assigned to three groups: two intervention groups (saline nose drops; medicated nose drops) and a control group (no nose drops). Forty-six children returned for check-up two days later. Subjects in all three groups improved between first and second contact. There was no significant difference between the three groups. It is concluded that medicated nose drops are not essential in the treatment of upper respiratory infection and rhinitis.